NCT07596966 EFFECTS OF PROPOLIS AND ROYAL JELLY SUPPLEMENTATION ON INFLAMMATORY AND OXIDATIVE STRESS MARKERS IN PATIENTS WITH SYSTEMIC ARTERIAL HYPERTENSION
| NCT ID | NCT07596966 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidade Federal Fluminense |
| Condition | Systemic Arterial Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2025-10-15 |
| Primary Completion | 2026-12-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2025-10-15 with a primary completion date of 2026-12-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to evaluate the effect of the royal jelly and propolis on inflammation and oxidative stress in participants with systemic arterial hypertension. A longitudinal double-blind randomized clinical trial will be carried out, involving hypertensive participants for two months.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of stage 1 and 2 hypertension * Regular treatment for more than 6 months * There have been no changes in medication doses over the last three months. Exclusion Criteria: * Autoimmune and infectious diseases, diabetes * Chronic kidney disease, liver disease, cancer and AIDS * Pregnant women * Use of catabolic drugs or antibiotics * Use of antioxidant vitamin supplements, prebiotics, probiotics, symbiotic * Habitual intake of royal jelly and propolis
Contact & Investigator
Ludmila Cardozo, PhD
STUDY DIRECTOR
Universidade Federal Fluminense
Frequently Asked Questions
Who can join the NCT07596966 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Systemic Arterial Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07596966 currently recruiting?
Yes, NCT07596966 is actively recruiting participants. Contact the research team at dmafra30@gmail.com for enrollment information.
Where is the NCT07596966 trial being conducted?
This trial is being conducted at Niterói, Brazil.
Who is sponsoring the NCT07596966 clinical trial?
NCT07596966 is sponsored by Universidade Federal Fluminense. The principal investigator is Ludmila Cardozo, PhD at Universidade Federal Fluminense. The trial plans to enroll 48 participants.